GemPharmatech Co., Ltd. (SHA:688046)

China flag China · Delayed Price · Currency is CNY
20.66
+0.20 (0.98%)
At close: Apr 29, 2026
81.71%
Market Cap 8.47B
Revenue (ttm) 830.61M
Net Income (ttm) 159.76M
Shares Out 410.00M
EPS (ttm) 0.40
PE Ratio 51.55
Forward PE 44.91
Dividend 0.14 (0.68%)
Ex-Dividend Date Nov 20, 2025
Volume 9,191,168
Average Volume 9,971,885
Open 20.26
Previous Close 20.46
Day's Range 19.51 - 20.92
52-Week Range 11.05 - 21.18
Beta 0.69
RSI 72.78
Earnings Date Apr 23, 2026

About GemPharmatech

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other se... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 1,578
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688046
Full Company Profile

Financial Performance

In 2025, GemPharmatech's revenue was 793.39 million, an increase of 15.51% compared to the previous year's 686.84 million. Earnings were 142.64 million, an increase of 29.88%.

Financial Statements

News

There is no news available yet.